EcoDrugPlus

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSONIG00000015778
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSONIG00000012609
Gene Symbol: FGFR1
1 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSONIG00000011012
Gene Symbol: FGFR1A
1 Cross references
205 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSONIG00000010192
Gene Symbol: FGFR2
1 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSONIG00000012350
Gene Symbol: FGFR3
4 Cross references
193 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSONIG00000014141
Gene Symbol: FLT1
1 Cross references
198 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSONIG00000017793
Gene Symbol: FLT4
4 Cross references
193 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSONIG00000005154
Gene Symbol: FOLH1B
4 Cross references
339 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSONIG00000035656
Gene Symbol: LOC100710946
4 Cross references
436 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSONIG00000036205
Gene Symbol: LOC100707205
2 Cross references
338 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSONIG00000011345
Gene Symbol: FRK
4 Cross references
202 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSONIG00000002489
Gene Symbol: GLA
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).